Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.57
-0.12-2.56%
At close: Dec 3, 4:00 PM EST
$5.00
0.439.41%
Pre-Market: 4:00 AM EST
Comments
Loading...
CalciMedica Analyst Ratings and Price Targets | NASDAQ:CALC | Benzinga
CalciMedica Inc has a consensus price target of $18 based on the ratings of 6 analysts. The high is $22 issued by JonesTrading on February 16, 2024. The low is $13 issued by LUCID CAPITAL MARKETS on December 17, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 15, 2025, April 1, 2025, and March 4, 2025, respectively. With an average price target of $16 between HC Wainwright & Co., there's an implied 220.00% upside for CalciMedica Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
LUCID CAPITAL MARKETS
Oppenheimer
HC Wainwright & Co.
JonesTrading
1calculated from analyst ratings
Analyst Ratings for CalciMedica
Get Alert | |||||
|---|---|---|---|---|---|
May 15, 2025 | 220% | Previous Buy Current Buy | |||
Apr 1, 2025 | 220% | Previous Buy Current Buy | |||
Mar 4, 2025 | 220% | Previous Buy Current Buy | |||
Dec 17, 2024 | 160% | Previous Initiates Current Buy | |||
Nov 14, 2024 | 220% | Previous Buy Current Buy | |||
Nov 4, 2024 | 220% | Previous Buy Current Buy | |||
Aug 13, 2024 | 300% | Previous Buy Current Buy | |||
Jul 10, 2024 | 300% | Previous Outperform Current Outperform | |||
Jul 9, 2024 | 300% | Previous Buy Current Buy | |||
Jun 27, 2024 | 300% | Previous Buy Current Buy | |||
May 14, 2024 | 300% | Previous Buy Current Buy | |||
Apr 1, 2024 | 300% | Previous Buy Current Buy | |||
Apr 1, 2024 | 180% | Previous Outperform Current Outperform | |||
Mar 13, 2024 | 300% | Previous Buy Current Buy | |||
Feb 16, 2024 | 340% | Previous Initiates Current Buy | |||
Feb 13, 2024 | 300% | Previous Buy Current Buy | |||
Jan 29, 2024 | 300% | Previous Initiates Current Buy | |||
Nov 13, 2023 | 180% | Previous Outperform Current Outperform | |||
Jul 7, 2023 | 240% | Previous Buy Current Buy | |||
Jun 20, 2023 | 240% | Previous Initiates Current Buy | |||
May 16, 2023 | 180% | Previous Current Outperform | |||
Mar 24, 2023 | 180% | Previous Initiates Current Outperform |
FAQ
What is the target price for CalciMedica (CALC) stock?
The latest price target for CalciMedica (NASDAQ:CALC) was reported by HC Wainwright & Co. on May 15, 2025. The analyst firm set a price target for $16.00 expecting CALC to rise to within 12 months (a possible 220.00% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CalciMedica (CALC)?
The latest analyst rating for CalciMedica (NASDAQ:CALC) was provided by HC Wainwright & Co., and CalciMedica reiterated their buy rating.
When was the last upgrade for CalciMedica (CALC)?
There is no last upgrade for CalciMedica
When was the last downgrade for CalciMedica (CALC)?
There is no last downgrade for CalciMedica.
When is the next analyst rating going to be posted or updated for CalciMedica (CALC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CalciMedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CalciMedica was filed on May 15, 2025 so you should expect the next rating to be made available sometime around May 15, 2026.
Is the Analyst Rating CalciMedica (CALC) correct?
While ratings are subjective and will change, the latest CalciMedica (CALC) rating was a reiterated with a price target of $16.00 to $16.00. The current price CalciMedica (CALC) is trading at is $5.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
